We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

14 hedge funds and large institutions have $85.4M invested in Xtant Medical Holdings in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,568% more capital invested

Capital invested by funds: $2.33M → $85.4M (+$83.1M)

37.34% more ownership

Funds ownership: 45.92%83.26% (+37%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

26% less funds holding

Funds holding: 1914 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
14
Holders Change
-5
Holders Change %
-26.32%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
5
Closed
7
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q1 2018 in Review

14 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q1 2018, worth a combined $85.4M — up 3,568% from $2.33M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of XTNT and 2 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was OrbiMed, adding an estimated $58M. The largest seller was Northern Trust, exiting entirely with an estimated $1.47M sold.

  • 14 institutional investors held Xtant Medical Holdings (XTNT) as of Q1 2018, down from 19 in Q4 2017.
  • Funds reported $85.4M of Xtant Medical Holdings stock for Q1 2018, up 3,568% quarter-over-quarter.
  • 2 funds opened new Xtant Medical Holdings positions in Q1 2018 and 7 closed out, a net change of -5 holders.
  • The largest Xtant Medical Holdings buyer in Q1 2018 was OrbiMed, an estimated $58M added.
  • The largest Xtant Medical Holdings seller in Q1 2018 was Northern Trust, an estimated $1.47M sold.

Based on aggregated 13F filings for Q1 2018.